Neuropharmacology of Rhodiola rosea L.

  • Amritpal Singh Saroya
  • Jaswinder Singh


R. rosea (Crassulaceae) is commonly known as roseroot (Sagalov 1983). The plant is native to dry, high-altitude regions of the northern hemisphere. R. rosea is better described as adaptogen in herbal medicine. R. rosea is a herbaceous perennial plant with a thick rhizome. R. rosea is one of the best-known herbal remedies for fatigue (Tharakan and Manyam 2006).


  1. Amsterdam JD, Panossian AG. Rhodiola rosea L. as a putative botanical antidepressant. Phytomedicine. 2016;23:770–83.CrossRefPubMedGoogle Scholar
  2. Andreeva L, Boĭkova AA, Nikiforova DV. Evaluating adaptogenic properties of Rhodiola rosea extract in human mononuclear cell culture and rat tissues. Eksp Klin Farmakol. 2013;76:23–7.PubMedGoogle Scholar
  3. Atochin DN, Chernysheva GA, Smolyakova VI, Osipenko AN, Logvinov SV, Zhdankina AA, Sysolyatin SV, Kryukov YA, Anfinogenova Y, Plotnikova TM, Plotnikov MB. Neuroprotective effects of p-tyrosol after the global cerebral ischemia in rats. Phytomedicine. 2016;23:784–92.CrossRefPubMedGoogle Scholar
  4. Bystritsky A, Kerwin L, Feusner JD. A pilot study of Rhodiola rosea (Rhodax) for generalized anxiety disorder (GAD). J Altern Complement Med. 2008;14:175–80.CrossRefPubMedGoogle Scholar
  5. Cayer C, Ahmed F, Filion V, Saleem A, Cuerrier A, Allard M, Rochefort G, Merali Z, Arnason JT. Characterization of the anxiolytic activity of Nunavik Rhodiola rosea. Planta Med. 2013;79:1385–91.CrossRefPubMedGoogle Scholar
  6. Chen QG, Zeng YS, Tang JY, Qin YJ, Chen SJ, Zhong ZQ. Effects of Rhodiola rosea on body weight and intake of sucrose and water in depressive rats induced by chronic mild stress. Zhong Xi Yi Jie He Xue Bao. 2008;6:952–5.CrossRefPubMedGoogle Scholar
  7. Chen QG, Zeng YS, Qu ZQ, Tang JY, Qin YJ, Chung P, Wong R, Hägg U. The effects of Rhodiola rosea extract on 5-HT level, cell proliferation and quantity of neurons at cerebral hippocampus of depressive rats. Phytomedicine. 2009;16:830–8.CrossRefPubMedGoogle Scholar
  8. Darbinyan V, Aslanyan G, Amroyan E, Gabrielyan E, Malmström C, Panossian A. Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression. Nord J Psychiatry. 2007;61:343–8.CrossRefPubMedGoogle Scholar
  9. Lai W, Zheng Z, Zhang X, Wei Y, Chu K, Brown J, Hong G, Chen L. Salidroside-mediated neuroprotection is associated with induction of early growth response genes (Egrs) across a wide therapeutic window. Neurotox Res. 2015;28:108–21.CrossRefPubMedGoogle Scholar
  10. Mao JJ, Xie SX, Zee J, Soeller I, Li QS, Rockwell K, Amsterdam JD. Rhodiola rosea versus sertraline for major depressive disorder: a randomized placebo-controlled trial. Phytomedicine. 2015;22:394–9.CrossRefPubMedPubMedCentralGoogle Scholar
  11. Mattioli L, Perfumi M. Rhodiola rosea L. extract reduces stress- and CRF-induced anorexia in rats. J Psychopharmacol. 2007;21:742–50.CrossRefPubMedGoogle Scholar
  12. Mattioli L, Funari C, Perfumi M. Effects of Rhodiola rosea L. extract on behavioural and physiological alterations induced by chronic mild stress in female rats. J Psychopharmacol. 2009;23:130–42.CrossRefPubMedGoogle Scholar
  13. Olsson EM, von Schéele B, Panossian AG. A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract shr-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue. Planta Med. 2009;75:105–12.CrossRefPubMedPubMedCentralGoogle Scholar
  14. Panossian A, Wikman G, Sarris J. Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy. Phytomedicine. 2010;17:481–93.CrossRefPubMedPubMedCentralGoogle Scholar
  15. Perfumi M, Mattioli L. Adaptogenic and central nervous system effects of single doses of 3% rosavin and 1% salidroside Rhodiola rosea L. extract in mice. Phytother Res. 2007;21:37–43.CrossRefPubMedPubMedCentralGoogle Scholar
  16. Petkov VD, Yonkov D, Mosharoff A, Kambourova T, Alova L, Petkov VV, et al. Effects of alcohol aqueous extract from Rhodiola rosea L. roots on learning and memory. Acta Physiol Pharmacol Bulg. 1986;12:3–16.PubMedPubMedCentralGoogle Scholar
  17. Qin YJ, Zeng YS, Zhou CC, Li Y, Zhong ZQ. Effects of Rhodiola rosea on level of 5-hydroxytryptamine, cell proliferation and differentiation, and number of neuron in cerebral hippocampus of rats with depression induced by chronic mild stress. Zhongguo Zhong Yao Za Zhi. 2008;33:2842–6.PubMedGoogle Scholar
  18. Ross SM. Rhodiola rosea (SHR-5), Part 2: a standardized extract of Rhodiola rosea is shown to be effective in the treatment of mild to moderate depression. Holist Nurs Pract. 2014a;28:217–21.CrossRefPubMedGoogle Scholar
  19. Ross SM. Rhodiola rosea (SHR-5), Part I: a proprietary root extract of Rhodiola rosea is found to be effective in the treatment of stress-related fatigue. Holist Nurs Pract. 2014b;28:149–54.CrossRefPubMedGoogle Scholar
  20. Sagalov GM. Rhodiola rosea. Feldsher Akush. 1983;48:55–6.PubMedGoogle Scholar
  21. Sheng QS, Wang ZJ, Zhang J, Zhang YG. Salidroside promotes peripheral nerve regeneration following crush injury to the sciatic nerve in rats. Neuroreport. 2013;24:217–23.CrossRefPubMedGoogle Scholar
  22. Shi TY, Feng SF, Xing JH, Wu YM, Li XQ, Zhang N, Tian Z, Liu SB, Zhao MG. Neuroprotective effects of Salidroside and its analogue tyrosol galactoside against focal cerebral ischemia in vivo and H2O2-induced neurotoxicity in vitro. Neurotox Res. 2012;21:358–67.CrossRefPubMedGoogle Scholar
  23. Sun L, Isaak CK, Zhou Y, Petkau JC, O K LY, Siow YL. Salidroside and tyrosol from Rhodiola protect H9c2 cells from ischemia/reperfusion-induced apoptosis. Life Sci. 2012;91:151–8.CrossRefPubMedGoogle Scholar
  24. Tharakan B, Manyam BV. Botanical therapies in chronic fatigue. Phytothear Res. 2006;20:91–5.CrossRefGoogle Scholar
  25. Thieme H. On the identity of glucoside rhodioloside and salidroside. Pharmazie. 1969;24:118–9.PubMedGoogle Scholar
  26. Tolonen A, Pakonen M, Hohtola A, Jalonen J. Phenylpropanoid glycosides from Rhodiola rosea. Chem Pharm Bull (Tokyo). 2003;51:467–70.CrossRefGoogle Scholar
  27. van Diermen D, Marston A, Bravo J, Reist M, Carrupt PA, Hostettmann K. Monoamine oxidase inhibition by Rhodiola rosea L. roots. J Ethnopharmacol. 2009;122:397–401.CrossRefPubMedGoogle Scholar
  28. Vasileva LV, Getova DP, Doncheva ND, Marchev AS, Georgiev MI. Beneficial effect of commercial Rhodiola extract in rats with scopolamine-induced memory impairment on active avoidance. J Ethnopharmacol. 2016;193:586–91.CrossRefPubMedGoogle Scholar
  29. Yan ZQ, Chen J, Xing GX, Huang JG, Hou XH, Zhang Y. Salidroside prevents cognitive impairment induced by chronic cerebral hypoperfusion in rats. J Int Med Res. 2015;43:402–11.CrossRefPubMedGoogle Scholar
  30. Yang SJ, Yu HY, Kang DY, Ma ZQ, Qu R, Fu Q, Ma SP. Antidepressant-like effects of salidroside on olfactory bulbectomy-induced pro-inflammatory cytokine production and hyperactivity of HPA axis in rats. Pharmacol Biochem Behav. 2014;124:451–7.CrossRefPubMedGoogle Scholar
  31. Zhang L, Yu H, Sun Y, Lin X, Chen B, Tan C, Cao G, Wang Z. Protective effects of salidroside on hydrogen peroxide-induced apoptosis in SH-SY5Y human neuroblastoma cells. Eur J Pharmacol. 2007;564:18–25.CrossRefPubMedGoogle Scholar
  32. Zhang L, Yu H, Zhao X, Lin X, Tan C, Cao G, Wang Z. Neuroprotective effects of salidroside against beta-amyloid-induced oxidative stress in SH-SY5Y human neuroblastoma cells. Neurochem Int. 2010;57:547–55.CrossRefPubMedGoogle Scholar
  33. Zhang X, Du Q, Liu C, Yang Y, Wang J, Duan S, Duan J. Rhodioloside ameliorates depressive behavior via up-regulation of monoaminergic system activity and anti-inflammatory effect in olfactory bulbectomized rats. Int Immunopharmacol. 2016;36:300–4.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2018

Authors and Affiliations

  • Amritpal Singh Saroya
    • 1
  • Jaswinder Singh
    • 2
  1. 1.Herbal ConsultantMohaliIndia
  2. 2.Department of PharmacologySri Guru Ram Das Institute of Medical ScienceAmritsarIndia

Personalised recommendations